Results 221 to 230 of about 36,146 (282)

Bioinformatics and Network Pharmacology Explore the Role of Immune Cells in the Occurrence of Anti-Vascular Endothelial Growth Factor (VEGF) Resistance in Patients with Neovascular Age-Related Macular Degeneration(nAMD) and the Application of Complementary Medicine Treatment

Mingyan Wang, Hongwei Li, Yan Wu, Bingqi Wang, Ya Xi, Kaifeng Hu   +5 more
openalex   +1 more source

Clinical Features and Optical Coherence Tomography Angiography in Neovascular Age-Related Macular Degeneration and Pachychoroid Neovasculopathy. [PDF]

J Vitreoretin Dis
Khaohoen A, Chantarasorn Y.
europepmc   +1 more source

Clinical Characteristics and Long-Term Outcomes of Eyes With Neovascular Age-Related Macular Degeneration Requiring Frequent Treatment. [PDF]

J Vitreoretin Dis
Salabati M, Garrigan H, Momenaei B, Wakabayashi T, Wong JC, Patel D, Mahmoudzadeh R, Mansour HA, Ammar M, Xu D, Regillo CD.   +10 more
europepmc   +1 more source

One-Year Outcomes of Intravitreal Faricimab Injection in Treatment-Naïve Patients With Neovascular Age-Related Macular Degeneration. [PDF]

J Vitreoretin Dis
Okawa K, Maruyama-Inoue M, Chin JY, Inoue T, Yanagi Y, Kadonosono K.   +5 more
europepmc   +1 more source

Dysregulated serum lipid profiles in neovascular age-related macular degeneration revealed by UPLC‒MS/MS lipidomics. [PDF]

Lipids Health Dis
Qu Y, Liu Y, Fang J, Chen C, Cheng L, Xu X, Jin J, Chen X, Niu T, Wang H, Xing X, Shi X, Shen Y, Liu K.   +13 more
europepmc   +1 more source

Impact of Punctate Hyperfluorescence Status on Treatment Outcomes of Faricimab Versus Aflibercept in Neovascular Age-Related Macular Degeneration. [PDF]

J Clin Med
Kamao H, Goto K, Mizukawa K, Hiraki R, Miki A, Kimura S.   +5 more
europepmc   +1 more source

Vascular Endothelial Growth Factors in Eye Diseases. Pathophysiology and New Therapeutic Strategies for Retinal and Choroideal Angiogenesis (Verisuonikasvutekijöiden merkitys silmäsairauksissa. Patofysiologiaa ja uusia hoitomenetelmiä verkkokalvon ja suonikalvon angiogeneettisiin sairauksiin) [PDF]

Kinnunen, Kati
core  

Some of the next articles are maybe not open access.

Related searches:

Neovascular Age-Related Macular Degeneration

Ophthalmologica, 2012
<i>Purpose:</i> Neovascular age-related macular degeneration (AMD) is a leading cause of blindness, with an increasing incidence as the elderly population expands. Large, multi-center, randomized, clinical trials have been conducted exploring the safety and efficacy of anti-VEGF treatments. This paper aims to discuss the safety and efficacy
VERITTI, Daniele, SARAO, Valentina, LANZETTA, Paolo   +2 more
openaire   +3 more sources

Neovascular Age-Related Macular Degeneration

Ophthalmology, 2013
Age-related macular degeneration (AMD) progresses through early and intermediate to advanced stages, one of which is neovascular AMD (nAMD). A correct diagnosis of nAMD at an early stage is critical because unlike geographic atrophy, it can be treated with therapeutic agents.
Bianca S. Gerendas, Julia S. Kroisamer, Florian Sulzbacher, Ursula Schmidt-Erfurth   +3 more
openaire   +2 more sources

Neovascular Age-Related Macular Degeneration

2015
Age-related macular degeneration (AMD) is the leading cause of severe vision loss in individuals over the age of 50 years. Choroidal neovascularization (CNV) is the hallmark of 'wet' or 'exudative' AMD, and is responsible for approximately 90% of cases of severe vision loss due to AMD. Vascular endothelial growth factor (VEGF) is a key component in the
Jack, Shao, Maria M, Choudhary, Andrew P, Schachat   +2 more
openaire   +3 more sources